Developer docs
API playgroundTry for free, no card

Search company profiles

Archer Materials

Full company profile

uuid003h9sk

Namestring
Archer Materials
Legal namestring
Archer Materials Limited
Websiteurl
archerx.com.au
Company typeenum
Public
Founded yearint
2007
Descriptiontext

Archer Materials Limited (ASX: AXE) is an Australian quantum technology company developing two core platforms built on carbon-based semiconductor materials: the 12CQ chip, a carbon-nano-onion and graphene-based quantum computing and sensing component designed to be compatible with standard CMOS fabrication and operable at higher temperatures than conventional quantum processors, and the Biochip, a graphene field-effect transistor (gFET) biosensor targeting point-of-care blood diagnostics, with an initial application in blood potassium monitoring for chronic kidney disease, cardiovascular, and diabetes patients. Supporting technologies include on-chip Electrical Detection of Magnetic Resonance (EDMR), Single-Electron Transistor (SET) architectures for qubit readout, and graphene-based device platforms co-developed with Paragraf.

The company operates a capital-light IP licensing and partnership model rather than building complete quantum machines, targeting licensees across semiconductor manufacturing, quantum computing, and MedTech. Revenue is currently nil; the company is funded by equity raises (a A$15 million institutional placement in 2025) and Australian R&D tax incentives (A$2.1 million rebate received in January 2026), with cash of approximately A$10.3 million as of December 2025 providing an estimated 7.9 quarters of runway. Strategic partnerships include a three-year US$1.5 million agreement with IonQ to evaluate Australian deployment of IonQ's quantum systems, R&D alliances with IMEC (silicon-integrated biochip), CSIRO (quantum machine learning for fraud detection), Emergence Quantum, Paragraf, QMUL, and EPFL, and a historical partnership with IBM dating to 2020.

The company is led by co-founder and Executive Chairman Greg English and CEO Dr Simon Ruffell (appointed March 2025, previously Principal Hardware Engineering Manager at Microsoft and Senior Manager at Applied Materials), with a lean team of 11-50 employees split between offices in Sydney and Adelaide (Lot Fourteen). Target end-markets span healthcare and medical diagnostics, defense and government (including GPS-denied navigation and sovereign quantum capability), AI and advanced computing, mining and resources, and financial services, with operating geographies currently focused on Australia and the broader APAC region.

Short descriptiontext

Archer Materials (ASX: AXE) is an Australian pre-revenue quantum technology company developing the 12CQ carbon-based quantum computing chip and a graphene-based Biochip for point-of-care blood diagnostics, licensing its IP to semiconductor, MedTech, and quantum partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHaymarket, Australia
HQ citystring
Haymarket
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
quantum computing hardware, carbon-based semiconductors, biosensor diagnostics, quantum sensing technology, point-of-care medical devices
Industry1 code
PRIMARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
NAICS code2 codes
  • Semiconductor and Related Device Manufacturing334413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • Semiconductors & Related Devices3674
  • Laboratory Analytical Instruments3826
Product category
Quantum Computing Hardware
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1IP Licensing
TypeLicensing Royalties
Description

Archer Materials develops intellectual property designed to integrate with established semiconductor ecosystems and licenses this IP through industry partnerships rather than constructing complete quantum computing systems. Value is created through IP development and strategic collaboration.

archerx.com.au
2Quantum Cloud Services (IonQ Agreement)
TypeSubscription Recurring
Description

Three-year Quantum Compute Agreement with IonQ provides access to quantum simulator, advisory services, and Forte-class/Tempo-class quantum systems for Australian deployment assessment and customer base development.

itbrief.com.au
3Quantum Sensing Devices
TypeHardware Sales
Description

Quantum sensing applications for magnetometry, medical diagnostics, and GPS-denied navigation environments using carbon-based technology platform.

archerx.com.au
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1IonQ Quantum Compute Agreement - Three-year access package
ModelSubscriptionBilling cadenceMulti-year contract
Notes

US$250,000 initial payment on signing, US$250,000 installments every six months, totaling US$1.5 million over initial term

itbrief.com.au
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Archer Materials develops two primary technology platforms: the 12CQ chip, a carbon-based quantum computing and sensing chip built from carbon nano onions and graphene that is compatible with standard semiconductor fabrication processes, and the Biochip, a graphene field-effect transistor (gFET) ion-sensing biosensor for point-of-care medical diagnostics beginning with blood potassium monitoring. The company operates an IP licensing and partnership commercialization model, monetizing its technology through agreements with MedTech manufacturers, semiconductor companies, defense agencies, and research institutions rather than producing finished consumer products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Blood potassium measurement accuracy within ±0.3 mM, meeting CLIA requirements
+2 more records
Product overview1 text field

Archer Materials is developing a dual-platform technology portfolio comprising the 12CQ quantum computing chip and the Biochip biosensing platform. The 12CQ chip is a carbon-based quantum hardware component targeting qubit demonstration and quantum sensing applications, designed to integrate with existing semiconductor manufacturing infrastructure rather than building full-scale quantum machines. The Biochip is a silicon-integrated graphene field-effect transistor (gFET) biosensor for point-of-care medical diagnostics, beginning with blood potassium monitoring for chronic kidney disease. Both platforms share a common carbon-materials foundation, enabling knowledge transfer and capital efficiency across programs. The company operates a capital-light IP-licensing model, pursuing partnerships with research institutions and industry players to commercialize its technologies.

Product and service2 records
112CQ Chip
CategoryQuantum Computing Hardware
Description

The 12CQ Chip is a carbon-based quantum computing chip and sensing platform designed for scalable qubit demonstration and advanced quantum sensing. It leverages carbon quantum materials (carbon nano onions and graphene) that are compatible with standard semiconductor fabrication processes, targeting applications in quantum computing, precision magnetometry, and medical diagnostics. The chip is designed to be smaller, more cost-effective, and operable at higher temperatures than conventional quantum processors.

2Biochip
CategoryBiosensor / Medical Diagnostics
Description

The Biochip is a graphene-based ion-sensing biosensor platform (gFET) integrated into a lab-on-a-chip cartridge for point-of-care medical diagnostics. The initial application targets rapid, low-cost blood potassium monitoring for chronic kidney disease patients, with planned extension to other ion-sensing applications across health, agriculture, and industry. A beta prototype is targeted for 2026 to support clinical trial initiation and licensing negotiations with MedTech companies.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-07-01
Description

Three-year Quantum Compute Agreement providing Archer access to IonQ's Quantum Cloud, advisory services, and Forte-class/Tempo-class quantum systems. Archer will pay US$250,000 on signing plus US$250,000 every six months (US$1.5 million total). Partnership aims to assess feasibility of deploying an IonQ quantum computer in Australia to establish sovereign quantum computing capability.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Cooperative R&D program to develop graphene-based quantum devices for next-generation quantum computing hardware. Collaboration combines Paragraf's commercially scalable graphene manufacturing with Archer's expertise in quantum device architectures to create novel qubit detection architectures. Goal is to generate differentiated graphene-based technologies for quantum computing, advanced sensing, and next-generation electronics.

3CSIRO
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-11
Description

12-month research services agreement to develop Quantum Machine Learning (QML) models for fraud detection in financial transactions. Project focuses on developing hybrid quantum-classical models with prototype quantum models and performance benchmarks across simulated financial datasets. Builds upon CSIRO's expertise in QML model development.

archerx.com.au
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-29
Description

Partnership to develop silicon-integrated Biochip for blood potassium sensing. IMEC leverages semiconductor technology and expertise to enable graphene and silicon-based devices during testing. First results confirmed silicon devices meet blood potassium accuracy requirements and clinical CLIA standards, with shorter conditioning times of ~30 minutes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-17
Description

Two-phase Innovation and Commercialisation Program focusing on graphene and carbon-based materials for quantum and non-quantum applications. Phase I involves mapping graphene's potential across quantum domains; Phase II involves experimental validation and prototype development. Emergence Quantum brings world-class capability and experience from work with multinational quantum companies.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Collaboration on qubit development, including extended partnership agreement for carbon qubit research and EDMR breakthrough progress.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Research collaboration to improve electron spin coherence for qubits. Validated model by engineering atomic defects like carbon vacancies and hydrogen chemisorption in carbon nanosphere material, showing spin polarisation spreads over ~5 nm.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Historical partnership announced in 2020 where Archer claimed to be the first Australian company building a quantum computing processor and hardware, with the CQ qubit processor chip.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Trapped-ion quantum computing company developing quantum hardware and cloud-access services. Directly comparable as a quantum computing hardware platform; also a strategic partner of Archer via the three-year Quantum Compute Agreement.

TypeDirect peer
Description

Photonic quantum computing company pursuing fault-tolerant quantum systems at scale. Comparable in its pursuit of a fundamentally different quantum hardware modality aimed at overcoming the limitations of superconducting and trapped-ion approaches.

TypeDirect peer
Description

UK-based company commercializing graphene-based electronic devices including sensors. Directly comparable as a graphene-electronics hardware company; also an active R&D partner of Archer in developing graphene-based quantum devices.

4Abbott Point of Care
TypeBroad incumbent
Description

Major medical device company operating the i-STAT point-of-care blood diagnostics platform. Comparable as a broad incumbent in point-of-care diagnostics that could be a potential licensing or acquisition target for Archer's Biochip technology.

TypeDirect peer
Description

Publicly listed superconducting quantum computing hardware developer offering cloud quantum services. Comparable as a small-cap, pre-commercial quantum hardware company pursuing a similar pathway of building quantum IP and partner-based commercial scale-up.

TypeDirect peer
Description

Small-cap quantum hardware and software company developing quantum sensing, computing, and cybersecurity solutions. Closely comparable as a publicly listed, pre-revenue quantum technology company pursuing multiple end-market applications.

TypeEmerging player
Description

Graphene materials supplier and developer of graphene-based biosensors and electronic devices. Comparable as a graphene technology company working on biosensing applications overlapping with Archer's Biochip platform.

TypeDirect peer
Description

Publicly listed quantum computing company selling annealing quantum systems and quantum cloud access. Comparable as a small-cap, publicly listed pure-play quantum hardware company with similar capitalization profile and commercialization timeline.

TypeDirect peer
Description

Trapped-ion quantum computing company formed from Honeywell and Cambridge Quantum. Comparable as a developer of full-stack quantum hardware and software pursuing commercial quantum advantage.

TypeBroad incumbent
Description

Division of IBM offering superconducting quantum hardware, Qiskit software platform, and quantum cloud services. Comparable as the broad incumbent in quantum computing with whom Archer has historical partnership ties; represents the scale and resources against which Archer competes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Archer Materials

Quantum Computing Hardwarearcherx.com.au

Archer Materials (ASX: AXE) is an Australian pre-revenue quantum technology company developing the 12CQ carbon-based quantum computing chip and a graphene-based Biochip for point-of-care blood diagnostics, licensing its IP to semiconductor, MedTech, and quantum partners.

What Archer Materials does

Archer Materials Limited (ASX: AXE) is an Australian quantum technology company developing two core platforms built on carbon-based semiconductor materials: the 12CQ chip, a carbon-nano-onion and graphene-based quantum computing and sensing component designed to be compatible with standard CMOS fabrication and operable at higher temperatures than conventional quantum processors, and the Biochip, a graphene field-effect transistor (gFET) biosensor targeting point-of-care blood diagnostics, with an initial application in blood potassium monitoring for chronic kidney disease, cardiovascular, and diabetes patients. Supporting technologies include on-chip Electrical Detection of Magnetic Resonance (EDMR), Single-Electron Transistor (SET) architectures for qubit readout, and graphene-based device platforms co-developed with Paragraf.

The company operates a capital-light IP licensing and partnership model rather than building complete quantum machines, targeting licensees across semiconductor manufacturing, quantum computing, and MedTech. Revenue is currently nil; the company is funded by equity raises (a A$15 million institutional placement in 2025) and Australian R&D tax incentives (A$2.1 million rebate received in January 2026), with cash of approximately A$10.3 million as of December 2025 providing an estimated 7.9 quarters of runway. Strategic partnerships include a three-year US$1.5 million agreement with IonQ to evaluate Australian deployment of IonQ's quantum systems, R&D alliances with IMEC (silicon-integrated biochip), CSIRO (quantum machine learning for fraud detection), Emergence Quantum, Paragraf, QMUL, and EPFL, and a historical partnership with IBM dating to 2020.

The company is led by co-founder and Executive Chairman Greg English and CEO Dr Simon Ruffell (appointed March 2025, previously Principal Hardware Engineering Manager at Microsoft and Senior Manager at Applied Materials), with a lean team of 11-50 employees split between offices in Sydney and Adelaide (Lot Fourteen). Target end-markets span healthcare and medical diagnostics, defense and government (including GPS-denied navigation and sovereign quantum capability), AI and advanced computing, mining and resources, and financial services, with operating geographies currently focused on Australia and the broader APAC region.

Archer Materials firmographics

Firmographics
Name
Archer Materials
Legal name
Archer Materials Limited
Website
https://archerx.com.au
Company type
Public
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
Archer Materials (ASX: AXE) is an Australian pre-revenue quantum technology company developing the 12CQ carbon-based quantum computing chip and a graphene-based Biochip for point-of-care blood diagnostics, licensing its IP to semiconductor, MedTech, and quantum partners.
Ownership category
akta.pro rank

Archer Materials industry classification

Industry
Product category
Quantum Computing Hardware
NAICS
Semiconductor and Related Device Manufacturing (334413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
Semiconductors & Related Devices (3674), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)

Keywords

  • Quantum computing hardware
  • Carbon-based semiconductors
  • Biosensor diagnostics
  • Quantum sensing technology
  • Point-of-care medical devices

Where Archer Materials is headquartered

Location

Headquarters

HQ city
Haymarket
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Archer Materials business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. IP Licensing: Archer Materials develops intellectual property designed to integrate with established semiconductor ecosystems and licenses this IP through industry partnerships rather than constructing complete quantum computing systems. Value is created through IP development and strategic collaboration.
  2. Quantum Cloud Services (IonQ Agreement): Three-year Quantum Compute Agreement with IonQ provides access to quantum simulator, advisory services, and Forte-class/Tempo-class quantum systems for Australian deployment assessment and customer base development.
  3. Quantum Sensing Devices: Quantum sensing applications for magnetometry, medical diagnostics, and GPS-denied navigation environments using carbon-based technology platform.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractIonQ Quantum Compute Agreement - Three-year access package

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Archer Materials product offering

Product offering

Core offering

Archer Materials develops two primary technology platforms: the 12CQ chip, a carbon-based quantum computing and sensing chip built from carbon nano onions and graphene that is compatible with standard semiconductor fabrication processes, and the Biochip, a graphene field-effect transistor (gFET) ion-sensing biosensor for point-of-care medical diagnostics beginning with blood potassium monitoring. The company operates an IP licensing and partnership commercialization model, monetizing its technology through agreements with MedTech manufacturers, semiconductor companies, defense agencies, and research institutions rather than producing finished consumer products.

Product overview

Archer Materials is developing a dual-platform technology portfolio comprising the 12CQ quantum computing chip and the Biochip biosensing platform. The 12CQ chip is a carbon-based quantum hardware component targeting qubit demonstration and quantum sensing applications, designed to integrate with existing semiconductor manufacturing infrastructure rather than building full-scale quantum machines. The Biochip is a silicon-integrated graphene field-effect transistor (gFET) biosensor for point-of-care medical diagnostics, beginning with blood potassium monitoring for chronic kidney disease. Both platforms share a common carbon-materials foundation, enabling knowledge transfer and capital efficiency across programs. The company operates a capital-light IP-licensing model, pursuing partnerships with research institutions and industry players to commercialize its technologies.

Differentiator

Problem solved

Functional benefit

Products and services

  • 12CQ Chip The 12CQ Chip is a carbon-based quantum computing chip and sensing platform designed for scalable qubit demonstration and advanced quantum sensing. It leverages carbon quantum materials (carbon nano onions and graphene) that are compatible with standard semiconductor fabrication processes, targeting applications in quantum computing, precision magnetometry, and medical diagnostics. The chip is designed to be smaller, more cost-effective, and operable at higher temperatures than conventional quantum processors.
  • Biochip The Biochip is a graphene-based ion-sensing biosensor platform (gFET) integrated into a lab-on-a-chip cartridge for point-of-care medical diagnostics. The initial application targets rapid, low-cost blood potassium monitoring for chronic kidney disease patients, with planned extension to other ion-sensing applications across health, agriculture, and industry. A beta prototype is targeted for 2026 to support clinical trial initiation and licensing negotiations with MedTech companies.

Quantifiable outcome

  • Blood potassium measurement accuracy within ±0.3 mM, meeting CLIA requirements
  • +2 more outcomes

Companies that use Archer Materials

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Archer Materials technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Archer Materials partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, core and supporting.

  • IonQflagshipStrategic or Co-development Partner · 1 July 2026Three-year Quantum Compute Agreement providing Archer access to IonQ's Quantum Cloud, advisory services, and Forte-class/Tempo-class quantum systems. Archer will pay US$250,000 on signing plus US$250,000 every six months (US$1.5 million total). Partnership aims to assess feasibility of deploying an IonQ quantum computer in Australia to establish sovereign quantum computing capability.
  • ParagrafcoreStrategic or Co-development Partner · 30 April 2026Cooperative R&D program to develop graphene-based quantum devices for next-generation quantum computing hardware. Collaboration combines Paragraf's commercially scalable graphene manufacturing with Archer's expertise in quantum device architectures to create novel qubit detection architectures. Goal is to generate differentiated graphene-based technologies for quantum computing, advanced sensing, and next-generation electronics.
  • CSIROcoreStrategic or Co-development Partner · 11 November 202512-month research services agreement to develop Quantum Machine Learning (QML) models for fraud detection in financial transactions. Project focuses on developing hybrid quantum-classical models with prototype quantum models and performance benchmarks across simulated financial datasets. Builds upon CSIRO's expertise in QML model development.
  • IMEC (Interuniversity Microelectronics Centre)coreStrategic or Co-development Partner · 29 October 2025Partnership to develop silicon-integrated Biochip for blood potassium sensing. IMEC leverages semiconductor technology and expertise to enable graphene and silicon-based devices during testing. First results confirmed silicon devices meet blood potassium accuracy requirements and clinical CLIA standards, with shorter conditioning times of ~30 minutes.
  • Emergence QuantumcoreStrategic or Co-development Partner · 17 October 2025Two-phase Innovation and Commercialisation Program focusing on graphene and carbon-based materials for quantum and non-quantum applications. Phase I involves mapping graphene's potential across quantum domains; Phase II involves experimental validation and prototype development. Emergence Quantum brings world-class capability and experience from work with multinational quantum companies.
  • Queen Mary University of London (QMUL)supportingStrategic or Co-development PartnerCollaboration on qubit development, including extended partnership agreement for carbon qubit research and EDMR breakthrough progress.
  • École Polytechnique Fédérale de Lausanne (EPFL)supportingStrategic or Co-development PartnerResearch collaboration to improve electron spin coherence for qubits. Validated model by engineering atomic defects like carbon vacancies and hydrogen chemisorption in carbon nanosphere material, showing spin polarisation spreads over ~5 nm.
  • IBMsupportingStrategic or Co-development PartnerHistorical partnership announced in 2020 where Archer claimed to be the first Australian company building a quantum computing processor and hardware, with the CQ qubit processor chip.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Archer Materials competitors and assessment

Company assessment

Direct peers

  • IonQ: Trapped-ion quantum computing company developing quantum hardware and cloud-access services. Directly comparable as a quantum computing hardware platform; also a strategic partner of Archer via the three-year Quantum Compute Agreement.
  • PsiQuantum: Photonic quantum computing company pursuing fault-tolerant quantum systems at scale. Comparable in its pursuit of a fundamentally different quantum hardware modality aimed at overcoming the limitations of superconducting and trapped-ion approaches.
  • Paragraf: UK-based company commercializing graphene-based electronic devices including sensors. Directly comparable as a graphene-electronics hardware company; also an active R&D partner of Archer in developing graphene-based quantum devices.
  • Rigetti Computing: Publicly listed superconducting quantum computing hardware developer offering cloud quantum services. Comparable as a small-cap, pre-commercial quantum hardware company pursuing a similar pathway of building quantum IP and partner-based commercial scale-up.
  • Quantum Computing Inc. Small-cap quantum hardware and software company developing quantum sensing, computing, and cybersecurity solutions. Closely comparable as a publicly listed, pre-revenue quantum technology company pursuing multiple end-market applications.
  • D-Wave Quantum: Publicly listed quantum computing company selling annealing quantum systems and quantum cloud access. Comparable as a small-cap, publicly listed pure-play quantum hardware company with similar capitalization profile and commercialization timeline.
  • Quantinuum: Trapped-ion quantum computing company formed from Honeywell and Cambridge Quantum. Comparable as a developer of full-stack quantum hardware and software pursuing commercial quantum advantage.

Broad incumbents

  • Abbott Point of Care: Major medical device company operating the i-STAT point-of-care blood diagnostics platform. Comparable as a broad incumbent in point-of-care diagnostics that could be a potential licensing or acquisition target for Archer's Biochip technology.
  • IBM Quantum: Division of IBM offering superconducting quantum hardware, Qiskit software platform, and quantum cloud services. Comparable as the broad incumbent in quantum computing with whom Archer has historical partnership ties; represents the scale and resources against which Archer competes.

Emerging players

  • Graphenea: Graphene materials supplier and developer of graphene-based biosensors and electronic devices. Comparable as a graphene technology company working on biosensing applications overlapping with Archer's Biochip platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Archer Materials social profiles

Digital presence

Archer Materials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Archer Materials leadership team

Management profile

Number of profiles

Profiles6 records

Archer Materials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Archer Materials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Archer Materials

What does Archer Materials do?

Archer Materials develops two primary technology platforms: the 12CQ chip, a carbon-based quantum computing and sensing chip built from carbon nano onions and graphene that is compatible with standard semiconductor fabrication processes, and the Biochip, a graphene field-effect transistor (gFET) ion-sensing biosensor for point-of-care medical diagnostics beginning with blood potassium monitoring. The company operates an IP licensing and partnership commercialization model, monetizing its technology through agreements with MedTech manufacturers, semiconductor companies, defense agencies, and research institutions rather than producing finished consumer products.

Is Archer Materials a public or private company?

Archer Materials is a public company. It is classified as public and is currently operating.

When was Archer Materials founded?

Archer Materials was founded in 2007. It employs 11 to 50 people.

Where is Archer Materials based?

Archer Materials is headquartered in Haymarket, Australia, in the Oceania region.

How does Archer Materials make money?

Three revenue lines are on record. IP Licensing is the primary driver. The others are quantum Cloud Services (IonQ Agreement) and quantum Sensing Devices.

Who are Archer Materials's main competitors?

Direct peers on record are IonQ, PsiQuantum, Paragraf, Rigetti Computing, Quantum Computing Inc., D-Wave Quantum and Quantinuum. Broad incumbents are Abbott Point of Care and IBM Quantum. Graphenea is listed as an emerging player.

Does Archer Materials have an API?

No public API is recorded for Archer Materials.

What industry is Archer Materials in?

Archer Materials's product category is Quantum Computing Hardware. Its primary akta.pro industry code is HDAHALAK, Biosensors & Lab-on-Chip (BioMEMS). Its NAICS code is 334413 and its SIC code is 3674.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Quantum ZeitgeistArcher Materials joins Australian quantum push at US CongressArcher Materials CEO Dr. Simon Ruffell and Executive Chair Greg English attended the Quantum World Congress in Maryland in September, joining a national delegation. The company, with IonQ as a strategic partner, aimed to build international partnerships and explore commercial opportunities for its quantum technologies.TipranksQuantum Computing News: IQM Hits Nasdaq as QLEP Raises $230 Million for Quantum Tech DealsMultiple quantum computing developments emerged this week as the sector moves deeper into public markets and government-backed infrastructure: IQM Quantum Computers completed a SPAC merger to list on Nasdaq, raising €198.7 million; Quantum Leap Acquisition Corp. completed a $230 million IPO targeting AI and quantum deals; Shanghai launched a quantum hub with 26 founding companies and up to $14.73 million in funding; Archer Materials signed a $1.5 million three-year agreement with IonQ for quantum access and exploring local deployment in Australia; and BTQ Technologies received French approval to acquire QPerfect's quantum emulator technology. The developments highlight increasing capital formation, cross-border partnerships, and national strategic interest in quantum technology globally.Quantum Computing ReportArcher Materials Partners with IonQ to Study On-Shore Sovereign Deployment and Accelerate QML Capital Markets ScalingArcher Materials has executed a three-year Quantum Compute Agreement with IonQ worth US$1.5 million, gaining access to IonQ's trapped-ion Forte-class and upcoming Tempo-class quantum hardware to study on-shore deployment of quantum computing infrastructure in Australia. The partnership will pair IonQ systems engineers with Archer's local hardware developers to deploy hybrid software applications targeting regulated verticals including defense, federal government, national security networks, and commercial banking institutions whose data residency laws prohibit overseas cloud routing. Archer's existing QML fraud detection model recently validated at 118 out of 148 simulated financial fraud events with a single false positive, and the company aims to translate the joint deployment study into formalized infrastructure proposals and enterprise client contracts over the next twelve months.AInvestArcher Materials Ltd: Archer enters strategic agreement with quantum leader, IonQArcher Materials Ltd has entered into a strategic collaboration with quantum innovation company Emergence Quantum to accelerate the development and commercialisation of next-generation quantum materials and devices, focusing on graphene and carbon-based materials. The partnership includes a phased Innovation and Commercialisation Program, with Phase I mapping graphene's potential across quantum and non-quantum applications, and Phase II involving experimental validation and prototype development. The company noted it remains pre-revenue with approximately A$13 million in cash, providing funding for roughly three years at its current burn rate.AInvestArcher Materials requests trading halt pending material capital raising announcementArcher Materials Limited has been granted a trading halt by the Australian Securities Exchange pending a material capital raising announcement, effective until October 5, 2026, or until the announcement is released. The company recently completed a $15 million institutional placement and as of June 2025 held AU$14 million in cash with no debt while maintaining a 12% reduction in cash burn rate. The halt suggests the upcoming announcement could involve further equity issuance or alternative financing mechanisms to support the quantum computing, biotechnology, and lithium-ion battery technology developer's operations.ZawyaParagraf and Archer Materials announce strategic collaboration on graphene‑based quantum devicesParagraf and Archer Materials announced a research and development program to develop graphene-based quantum computing hardware. The collaboration combines Paragraf's scalable graphene platform with Archer Materials' quantum device expertise to advance qubit detection and device structures. They expect to generate a pipeline of graphene-based technologies for quantum computing, sensing, and electronics.Graphene-InfoParagraf and Archer Materials announce strategic collaboration on graphene-based quantum devicesParagraf and Archer Materials have announced a cooperative research and development program focused on developing graphene-based quantum devices for next-generation quantum computing hardware. The collaboration aims to address critical scaling challenges in quantum computing by leveraging graphene's exceptional electronic properties, with the goal of creating novel qubit detection architectures that have not yet been demonstrated at either an academic or industrial level. The companies expect the partnership to generate a pipeline of differentiated graphene-based technologies addressing emerging markets in quantum computing, advanced sensing, and next-generation electronics.ThequantuminsiderParagraf and Archer Materials Announce Strategic Collaboration on Graphene‑Based Quantum DevicesParagraf and Archer Materials Ltd. have launched a cooperative R&D program to develop graphene-based device platforms for next-generation quantum computing hardware. The collaboration combines Paragraf's commercially scalable graphene manufacturing with Archer Materials' expertise in quantum device architectures to create novel structures for qubit detection and quantum measurement. The companies expect the partnership to generate a pipeline of differentiated technologies targeting quantum computing, advanced sensing, and next-generation electronics markets.TradingViewWhy Archer’s Technology Matters for Global IndustriesArcher Materials is pivoting its strategy to address bottlenecks in healthcare, data security, and aerospace through its silicon-integrated Biochip and quantum technology initiatives. The company aims to revolutionize medical diagnostics with quantitative blood testing for cardiovascular patients while developing Quantum Machine Learning models for fraud detection in partnership with CSIRO.MoomooArcher Materials Launches Quantum Machine Learning Initiative to Enhance Fraud Detection; Shares Up 3%Archer Materials announced the launch of a quantum machine learning initiative aimed at improving fraud detection, leading to a 3% increase in its shares. The article also mentions Unity Software's quarterly financial results, including a revenue increase of 35% year-over-year.